Over 20 years experience, across financial and health economics. Advisor and strategic partner to hundreds of MedTech companies, payers and policy makers globally. Supporting the adoption of innovation within global healthcare ecosystems.
Focusing on clinical, economic, and environmental outcomes across all 6 key stakeholder groups: Physicians, Providers, Payers, Procurement, Policy Makers and Patients.
Areas of expertise: MedTech Pricing, Market Access, Reimbursement, HTA, Policy, and system Sustainability. Technologies include: All types of Minimally Invasive Surgery, especially robotic surgery, vascular access, advanced diagnostics / genomics, respiratory / COPD, women’s health, oncology, sepsis, diabetes, artificial intelligence (AI).